Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.44) per share. This is unchanged from the same period last year. The company reported $515.00 thousand in sales this quarter.
Northland Capital Markets Maintains Outperform on Sangoma Technologies, Lowers Price Target to $13
Northland Capital Markets analyst Michael Latimore maintains Sangoma Technologies (NASDAQ:SANG) with a Outperform and lowers the price target from $15 to $13.
